Lexston Life Sciences funds whole genome sequencing project for Psilocybe allenii, an understudied psychedelic mushroom native to the Pacific Northwest18 Apr at 7:02 pm
LEXSTON LIFE SCIENCES IS GRANTED SECTION 56 EXEMPTION FROM HEALTH CANADA AND EMBARKS ON THE DEVELOPMENT OF PORTABLE TECHNOLOGY FOR QUANTIFICATION AND TRACEABILITY OF PSILOCYBE MUSHROOMS1 Feb at 4:47 am
LEXSTON ANNOUNCES FEDERAL FUNDING FOR CANNABIS TRANSFORMATION PROJECT THAT WILL RESULT IN ZERO THC VARIETIES20 Jan at 5:56 pm
LEXSTON ANNOUNCES A MEMORANDUM OF UNDERSTANDING TO COLLABBORATE ON PSYCHEDELICS RESEARCH AND DEVELOPMENT WITH ALVARIUS RESEARCH INC.12 Jan at 4:56 pm
LEXSTON ANNOUNCES A MEMORANDUM OF UNDERSTANDING WITH UNITED STATES BASED PANACEA PLANT SCIENCES INC. FOR RESEARCH AND DEVELOPMENT OF PSYCHEDELICS AND CANNABIS 10 Jan at 4:55 pm
